How has been the historical performance of Nexus Surgical?

Answer:The historical performance of Nexus Surgical shows a trend of increasing net sales and profitability over the years, particularly from March 2023 to March 2025.

Breakdown:
Nexus Surgical's net sales have shown significant growth, rising from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. This increase in total operating income mirrors the sales growth, with figures moving from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. The total expenditure, excluding depreciation, has also increased but at a slower pace, from 1.34 Cr in March 2023 to 5.06 Cr in March 2025, leading to an operating profit (PBDIT) that improved from 0.21 Cr in March 2023 to 0.67 Cr in March 2025. Profit before tax has similarly increased from 0.23 Cr in March 2023 to 0.67 Cr in March 2025, resulting in a profit after tax of 0.50 Cr in March 2025, up from 0.17 Cr in March 2023. The earnings per share (EPS) have also improved significantly, reaching 0.91 in March 2025 compared to 0.31 in March 2023. Despite these positive trends, the company's reserves remain negative, though they have improved from -5.12 Cr in March 2023 to -4.41 Cr in March 2025. The total assets have increased from 0.91 Cr in March 2023 to 1.80 Cr in March 2024, while total liabilities have also risen, indicating a growing but manageable financial position. Overall, Nexus Surgical has demonstrated a recovery and growth trajectory in its financial performance over the past few years.